SRXH SRX Global Inc.
Beverages · NYSE · SEC CIK 1471727 · Fiscal year ends 09/30
Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-187.8%
TTM net income YoY-24.0%
TTM EPS YoY295.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin22.2%
Operating margin-48.0%
Net margin138.1%
FCF margin—
EBITDA margin-36.8%
Returns
ROE-70.8%
ROA-38.4%
ROIC (approx.)27.3%
Asset turnover-0.28x
Leverage & solvency
Liabilities / assets1.6%
Debt / equity0.00x
Current ratio27.55x
Interest coverage2.79x
Cash quality & payout
Operating cash flow / net income—
Accruals ratio—
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-09-30 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $6.53M | $34.98M |
| Cost of revenue | $5.01M | $21.99M |
| Gross profit | $1.53M | $12.99M |
| R&D expense | — | $100,000 |
| SG&A expense | $12.93M | $18.96M |
| Operating income | -$11.41M | -$5.97M |
| Interest expense | $628,000 | $467,000 |
| Pretax income | -$8.64M | -$159,000 |
| Income tax | — | $9,000 |
| Net income | -$45.01M | -$168,000 |
| EBITDA | -$11.38M | -$5.84M |
| EPS (basic) | -2.13 | -0.10 |
| EPS (diluted) | -2.13 | -0.10 |
| Weighted avg. shares (diluted) | 21.11M | 1.62M |
| Balance sheet | ||
| Cash & equivalents | $1.31M | $3.07M |
| Receivables | $3.94M | $5.37M |
| Inventory | $2.08M | $3.87M |
| Current assets | $8.13M | $15.00M |
| PP&E, net | $88,000 | $138,000 |
| Goodwill | — | $405,000 |
| Total assets | $8.40M | $15.80M |
| Current liabilities | $3.54M | $7.15M |
| Short-term debt | — | $2.41M |
| Long-term debt | $0 | $2.41M |
| Total debt | $0 | $4.83M |
| Total liabilities | $8.00M | $7.15M |
| Shareholders' equity | $407,000 | -$63.67M |
| Net debt | -$1.31M | $1.76M |
| Shares outstanding | 416,542 | 1.83M |
| Cash flow statement | ||
| Operating cash flow | -$8.14M | -$4.36M |
| Capital expenditure | — | $41,000 |
| Free cash flow | — | -$4.40M |
| Investing cash flow | $5.91M | -$2.25M |
| Financing cash flow | $12.17M | $5.22M |
| Depreciation & amortization | $31,000 | $130,000 |
| Stock-based compensation | $3.21M | $833,000 |
Free plan shows the latest 2 periods; Pro shows all 27 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.